CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 11 enrolled
Drug / intervention
Carisbamate +1 moredrug
Likely dose
Carisbamate 600mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02435381
NCT02435381Phase 2Completed
CompareCT.gov

Carisbamate as a Potential Treatment for Alcohol Dependence

Baylor College of Medicine·interventional·Posted May 6, 2015·Updated Mar 2, 2021

In Brief

A Phase 2 clinical trial evaluating Carisbamate and Placebo for Alcohol Dependence and 2 related conditions. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the effects of treatment with carisbamate compared to treatment with placebo, on alcohol-induced stimulant and subjective effects in non-treatment seeking alcohol-dependent human volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Dependence, Alcohol Abuse, Substance Abuse
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 6, 2015
Enrollment StartFeb 1, 2013
Primary CompletionSep 30, 2013
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 11.2 years ago

Interventions

Carisbamatedrug

600mg Orally on days 2-4

Placebodrug

Placebo treatment only